scispace - formally typeset
G

Goodarz Danaei

Researcher at Harvard University

Publications -  192
Citations -  67656

Goodarz Danaei is an academic researcher from Harvard University. The author has contributed to research in topics: Population & Risk factor. The author has an hindex of 59, co-authored 173 publications receiving 55837 citations. Previous affiliations of Goodarz Danaei include Institute for Health Metrics and Evaluation & Imperial College London.

Papers
More filters
Journal ArticleDOI

Hypothetical interventions to prevent stroke: an application of the parametric g-formula to a healthy middle-aged population.

TL;DR: The parametric g-formula was applied to estimate the 18-years cumulative stroke risk under different scenarios of hypothetical interventions on levels of blood pressure, cholesterol, weight, physical activity, smoking and alcohol intake, and compared these to the observed scenario, to calculate the population risk ratios and risk differences.
Journal ArticleDOI

The Effect of HIV and the Modifying Effect of Anti-Retroviral Therapy (ART) on Body Mass Index (BMI) and Blood Pressure Levels in Rural South Africa

TL;DR: Short-term ART (0–<2 years) was associated with larger weight loss than either no ART or long- term ART, and the importance of health system readiness to address the burgeoning double burden of disease in South Africa is showcased.
Journal Article

Cardiovascular disease prevention using fixed dose pharmacotherapy in Iran: updated meta-analyses and mortality estimation.

TL;DR: Polypill can prevent a large number of IHD and stroke deaths in Iran and the cost-effectiveness, feasibility, and acceptability of this prevention strategy remain to be investigated.
Journal ArticleDOI

Integrating care for non-communicable diseases into routine HIV services: key considerations for policy design in sub-Saharan Africa.

TL;DR: In this paper, the authors summarized opportunities and challenges related to leveraging HIV treatment platforms to address NCDs among people living with HIV (PLHIV) versus targeting the general population.
Journal ArticleDOI

Global burden of infection-related cancer revisited.

TL;DR: An updated systematic analysis of the proportion of cancer cases attributable to infection globally and by region in 2008, using data on cancer incidence from the GLOBOCAN project, along with the most recent epidemiological evidence on the causal eff ect of each infection on cancer and the most reliable data on prevalence of infection among cases.